Edap Tms (NASDAQ:EDAP) Price Target Raised to $12.00

Edap Tms (NASDAQ:EDAPGet Rating) had its target price lifted by research analysts at HC Wainwright from $11.00 to $12.00 in a report issued on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. HC Wainwright’s price target would suggest a potential upside of 20.60% from the company’s current price.

A number of other research analysts have also commented on the company. StockNews.com started coverage on Edap Tms in a report on Wednesday, October 12th. They set a “hold” rating for the company. Jefferies Financial Group started coverage on Edap Tms in a report on Tuesday, November 1st. They set a “buy” rating and a $11.00 price target for the company. Finally, Piper Sandler upped their price target on Edap Tms from $11.00 to $12.00 in a report on Thursday.

Edap Tms Stock Down 3.8 %

Shares of Edap Tms stock opened at $9.95 on Friday. The stock has a market capitalization of $359.69 million, a P/E ratio of 90.46 and a beta of 1.22. The company has a quick ratio of 3.18, a current ratio of 4.37 and a debt-to-equity ratio of 0.08. The stock has a 50 day moving average price of $8.86 and a two-hundred day moving average price of $7.73. Edap Tms has a 12-month low of $5.13 and a 12-month high of $10.60.

Edap Tms (NASDAQ:EDAPGet Rating) last announced its earnings results on Wednesday, August 24th. The medical equipment provider reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.09. Edap Tms had a return on equity of 6.42% and a net margin of 6.76%. The firm had revenue of $14.97 million during the quarter, compared to analysts’ expectations of $14.17 million. Equities analysts expect that Edap Tms will post 0.02 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Rock Springs Capital Management LP raised its stake in shares of Edap Tms by 7.8% in the first quarter. Rock Springs Capital Management LP now owns 820,000 shares of the medical equipment provider’s stock valued at $5,945,000 after purchasing an additional 59,100 shares in the last quarter. Camarda Financial Advisors LLC acquired a new position in shares of Edap Tms in the first quarter valued at $209,000. JPMorgan Chase & Co. raised its stake in shares of Edap Tms by 80.3% in the second quarter. JPMorgan Chase & Co. now owns 14,943 shares of the medical equipment provider’s stock valued at $102,000 after purchasing an additional 6,654 shares in the last quarter. Jane Street Group LLC acquired a new position in shares of Edap Tms in the second quarter valued at $86,000. Finally, Envestnet Asset Management Inc. acquired a new position in shares of Edap Tms in the second quarter valued at $80,000. 28.53% of the stock is currently owned by institutional investors and hedge funds.

Edap Tms Company Profile

(Get Rating)

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST).

See Also

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.